Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Operating Leases (2018 - 2025)

Surgery Partners' Operating Leases history spans 7 years, with the latest figure at $333.1 million for Q4 2024.

  • For Q4 2024, Operating Leases fell 66.01% year-over-year to $333.1 million; the TTM value through Dec 2024 reached $333.1 million, down 66.01%, while the annual FY2024 figure was $333.1 million, 66.01% down from the prior year.
  • Operating Leases for Q4 2024 was $333.1 million at Surgery Partners, up from $250.5 million in the prior quarter.
  • Across five years, Operating Leases topped out at $980.1 million in Q4 2023 and bottomed at $250.5 million in Q1 2024.
  • The 5-year median for Operating Leases is $307.0 million (2020), against an average of $417.0 million.
  • The largest annual shift saw Operating Leases skyrocketed 218.32% in 2023 before it tumbled 66.01% in 2024.
  • A 5-year view of Operating Leases shows it stood at $300.9 million in 2020, then grew by 18.21% to $355.7 million in 2021, then dropped by 13.44% to $307.9 million in 2022, then surged by 218.32% to $980.1 million in 2023, then crashed by 66.01% to $333.1 million in 2024.
  • Per Business Quant, the three most recent readings for SGRY's Operating Leases are $333.1 million (Q4 2024), $250.5 million (Q1 2024), and $980.1 million (Q4 2023).